Vaccine Vigilance System: Considerations on the Effectiveness of Vigilance Data Use in COVID-19 Vaccination

(1) Background: The safety of medicines has been receiving increased attention to ensure that the risks of taking medicines do not outweigh the benefits. This is the reason why, over several decades, the pharmacovigilance system has been developed. The post-authorization pharmacovigilance system is...

Полное описание

Библиографические подробности

Главные авторы:	Diana Araja, Angelika Krumina, Zaiga Nora-Krukle, Uldis Berkis, Modra Murovska
Формат:	Artigo
Язык:	Inglês
Опубликовано:	MDPI AG 2022-12-01
Серии:	Vaccines
Предметы:	pharmacovigilance EudraVigilance COVID-19 vaccines adverse drug reactions (ADRs) chronic fatigue syndrome neurological and autoimmune diseases
Online-ссылка:	https://www.mdpi.com/2076-393X/10/12/2115
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!